Skip to content

Effectiveness of low-dose olanzapine for prevent postoperative nausea and vomiting after gynecologic laparoscopic surgery

Effectiveness of low-dose olanzapine for prevent postoperative nausea and vomiting after gynecologic laparoscopic surgery

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221027005
Enrollment
180
Registered
2022-10-27
Start date
2022-09-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient who undergoes gynecologic laparoscopic surgery Gynecologic laparoscopic surgery Postoperative nausea vomiting Low-dose olanzapine

Interventions

olanzapine (5mg ) 1-1.5 hrs before laparoscopic gynecologic surgery,placebo drug 1-1.5 hrs before laparoscopic gynecologic surgery
Experimental Drug,Placebo Comparator Drug
low-dose olanzapine,placebo drug

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patient who undergoes elective gynecologic laparoscopic surgery 2. The American Society of Anesthesiologists (ASA) Physical Status Classification I-III 3. Patient with age between 18-65 4.Patient who accept to be included in the project.

Exclusion criteria

Exclusion criteria: 1. Patient who have psychological symptoms. 2. Patient with pregnancy and breast feeding 3. Patient with morbid obesity 4. Patient with abnormal EKG (QT prolong ,Torsades de pointes) 5. Patient who have contraindication of olanzapine (drug allergy,parkinson disease,dementia) 6. Patient with severe metabolic disease 7. Patient who have indication for nasogastric tube after surgery 8. Patient with history of chemotherapy within 4 weeks before surgery 9. Patient who refuse to be included in the project.

Design outcomes

Primary

MeasureTime frame
Postoperative nausea/vomiting 24 hours postoperatively Verbal rating scale of nausea (VRS of nausea)

Secondary

MeasureTime frame
Postoperative nausea/vomiting post-dose at 0,6,12,24 hours Verbal rating scale of nausea (VRS of nausea),Mean blood pressure,heart rate post-dose at 0,6,12,24 hours Mean blood pressure,heart rate,opioid medication post-dose at 0,6,12,24 hours Total amount of opioid medication patient received,Rescue anti-emetic drugs post-dose at 0,6,12,24 hours Total amount of anti-emetic medication patient received,vomiting events post-dose at 0,6,12,24 hours Total amount of vomiting events,analgesic medication post-dose at 0,6,12,24 hours Total amount of analgesic medication,sedation scores post-dose at 0,6,12,24 hours sedation scores,PACU length of stay mins Total time PACU length of stay

Countries

Thailand

Contacts

Public ContactRattaphol Seangrung

Faculty of Medicine Ramathibodi Hospital, Mahidol University

rattaphol.ra@gmail.com0816880608

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026